| Asthma and COPD are the most commonly occurring respiratory diseases. Prescribing pattern are the drug utilization
studies that provides insight about pattern of drug use, quality, determinants, and outcome of drug use. Irrational
prescribing pattern is one of the major problems faced by healthcare. It can negatively impact health and economy for the
patient as well as society. The study aimed to evaluate the prescribing pattern of drugs used in Bronchial asthma and COPD
patients. A Prospective observational study was conducted in 80 patients (65 Asthma and 64 COPD respectively. The
prescribing pattern of drugs in Asthma and COPD was evaluated and relevant data were collected from the patients. In 80
prescriptions majority patients were males (42.1%) in Asthma, 76.1% in COPD and 11% were females in Asthma. Asthma
patients have longer duration of disease when compared with COPD patients. For Asthma patients, 19 were prescribed
antibiotics with Azithromycin being the highest at 15.7%, Ceftriaxone 10.5%, and Penicillin 2.6%. Inhaled SABA was
prescribed more for COPD patients (33.3%) than for Asthma patients (23.6%). In case of LABA Formoterol was
prescribed most in both Asthma and COPD (78.9% and 50% respectively). The overall utilization of drugs used in Asthma
and COPD was found to be: Antibiotics 29.2% in Asthma and 25 % in COPD, Anticholinergics 4.6% in Asthma and 25%
in COPD, SABA 13.8% in Asthma and 29.6% in COPD, LABA 60% in Asthma and 31.2% in COPD and Steroids 55.3%
in Asthma whereas 39.06% in COPD respectivelyddd |
